Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 68.2 TWD 0.89% Market Closed
Market Cap: 11.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Tanvex BioPharma Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tanvex BioPharma Inc
Capital Expenditures Peer Comparison

Comparables:
688235
6550

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Tanvex BioPharma Inc
TWSE:6541
Capital Expenditures
-NT$121.9m
CAGR 3-Years
-30%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Capital Expenditures
-ÂĄ4.1B
CAGR 3-Years
-61%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Polaris Group
TWSE:6550
Capital Expenditures
-NT$333.2m
CAGR 3-Years
-86%
CAGR 5-Years
-50%
CAGR 10-Years
N/A

See Also

What is Tanvex BioPharma Inc's Capital Expenditures?
Capital Expenditures
-121.9m TWD

Based on the financial report for Jun 30, 2024, Tanvex BioPharma Inc's Capital Expenditures amounts to -121.9m TWD.

What is Tanvex BioPharma Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-5%

Over the last year, the Capital Expenditures growth was -44%. The average annual Capital Expenditures growth rates for Tanvex BioPharma Inc have been -30% over the past three years , -5% over the past five years .

Back to Top